NQO2 Antilichaam

This gene encodes a member of the thioredoxin family of enzymes. It is a cytosolic and ubiquitously expressed flavoprotein that catalyzes the two-electron reduction of quinone substrates and uses dihydronicotinamide riboside as a reducing coenzyme. Mutations in this gene have been associated with neurodegenerative diseases and several cancers. Alternative splicing results in multiple transcript variants.

4835

P16083

Human, Mouse, Rat

Recombinant fusion protein containing a sequence corresponding to amino acids 1-1-231 of human NQO2 (NP_000895.2) .

Unconjugated

Primary Antibodies

Cell Cycle, Signal Transduction

Affinity purification

LO2

Batch dependent

PBS with 0.02% sodium azide, 50% glycerol, pH7.3.

None

Blue Ice

Store at -20˚ C. Avoid freeze / thaw cycles.

Observed: 26kDa

IgG

NQO2

293T

Mouse liver

Ribosyldihydronicotinamide dehydrogenase [quinone]

Homo sapiens

Ribosyldihydronicotinamide dehydrogenase [quinone], NRH dehydrogenase [quinone] 2, NRH:quinone oxidoreductase 2, Quinone reductase 2, QR2, NQO2, NMOR2

WB, IHC

Liquid